BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives $16.56 Consensus Price Target from Analysts
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) have received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month target price […]
More Stories
Sakamoto Days Season 2: Release Date, Trailer, and Where to Watch?
Sakamoto Days, the 2025 series, is coming back! For Sakamoto Days fans, the blend of action, comedy, and adventure is...
Is Blue Eye Samurai Season 2 Announced? Release Date, Trailer, and More
Netflix’s adult anime series, Blue Eye Samurai, first premiered in 2023 and has quickly become one of the most acclaimed...
Oasis Season 1 is Live on Netflix! Review, Rating, and Update on Season 2 Release
Netflix has released an all-new Spanish mystery thriller, Oasis, season 1. The series is full of thriller scenes and suspenseful...
Ricky Gervais’ Alley Cats Trailer is Out! Know the Release Date and Other Details
Ricky Gervais is coming back with an all-new adult animated series, Alley Cats. The theme is about the everyday life...
Better Late Than Single Season 2: Release Date, Contestants Details, Trailer, and More
Better Late Than Single is a South Korean reality show that first premiered on Netflix in July 2025. Better Late...
10 Best Animated Movies that You Can Binge-Watch on Netflix
Are you also an animation movie lover, just like me? Here, in this blog, I have mentioned some of the...